Long-term female hormone use a risk factor for breast cancer?

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1102, 2006-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term pioglitazone use doubles bladder cancer risk

Reactions Weekly, Vol. 1, Iss. 1405, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Extended Safety Profile of Oral Clodronate After Long-Term Use in Primary Breast Cancer Patients

By Atula S.

Drug Safety, Vol. 26, Iss. 9, 2003-01 ,pp. : 661-671

Adis International

Access to resources Recommend Favorite

Long-term immunosuppressant use may be linked to cancer

Reactions Weekly, Vol. 1, Iss. 1329, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancer

By Kang Hyunseok Gillespie Theresa W. Goodman Michael Brodie Seth A. Brandes Mina Ribeiro Maria Ramalingam Suresh S. Shin Dong M. Khuri Fadlo R. Brandes Johann Christoph

Cancer, Vol. 120, Iss. 9, 2014-05 ,pp. : 1394-1400

Blackwell Publishing

Access to resources Recommend Favorite

Tamoxifen: long-term benefit in ER-positive breast cancer

Inpharma, Vol. 1, Iss. 1584, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite